Table 2.
Intragroup and intergroup comparisons for subjective outcomes using repeated measures ANCOVA adjusting for fatigue symptoms (muscle pain, tender cervical or axillary lymph nodes) at baseline
| Baseline (T0) | 5 weeks after (T1)a | 4 months after (T2)a | Time × group effect | ||||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Effect size (d) | Mean (SD) | Effect size (d) | F | p | |
| Total fatigue score | |||||||
| Intervention group | 39.9 (6.3) | 26.3 (10.9)*** | −1.5 | 21.6 (10.4)*** | −2.1 | 12.93 | 0.000 |
| Control group | 39.7 (6.1) | 34.8 (8.0)** | −0.7 | 32.1 (8.8)*** | −1.0 | ||
| Physical fatigue score | |||||||
| Intervention group | 25.0 (3.7) | 15.2 (6.5)*** | −1.9 | 12.9 (6.1)*** | −2.4 | 20.09 | 0.000 |
| Control group | 24.7 (4.1) | 21.8 (5.1)** | −0.6 | 20.3 (5.7)*** | −0.9 | ||
| Mental fatigue score | |||||||
| Intervention group | 14.9 (3.6) | 11.1 (5.1)** | −0.9 | 8.8 (4.6)*** | −1.5 | 4.60 | 0.012 |
| Control group | 15.0 (3.2) | 13.0 (3.9)* | −0.6 | 11.9 (3.8)** | −0.9 | ||
| Physical functioning score | |||||||
| Intervention group | 36.9 (7.2) | 38.4 (6.1) | 0.2 | 40.1 (6.9) | 0.5 | 0.69 | 0.484 |
| Control group | 35.7 (7.1) | 37.5 (8.1) | 0.2 | 37.8 (5.6) | 0.3 | ||
| Mental functioning score | |||||||
| Intervention group | 32.5 (10.7) | 43.8 (6.9)** | 1.3 | 42.7 (7.2)** | 1.1 | 7.60 | 0.001 |
| Control group | 33.5 (9.6) | 34.6 (9.6) | 0.1 | 35.7 (9.5) | 0.2 | ||
*p < 0.05; **p < 0.01; ***p < .0.001
aCompared with baseline values